Literature DB >> 12386284

A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 null mutant mice develop renal lesions mimicking obstructive nephropathy.

Hitoshi Yokoyama1, Takashi Wada, Ken-ichi Kobayashi, Kouji Kuno, Hiroki Kurihara, Takayuki Shindo, Kouji Matsushima.   

Abstract

BACKGROUND: A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 is distinguished from other a disintegrin and metalloproteinase molecules by the presence of thrombospondin type 1 motifs at its C-terminus and anchors to the extracellular matrix. We studied the biological role of ADAMTS-1 in the kidney.
METHODS: We developed ADAMTS-1 null mice by replacing exons 2-4, which encode most of the metalloproteinase domain, with the neomycin resistance gene.
RESULTS: In normal mice, ADAMTS-1 was detected in the epithelial cells of collecting ducts, and more intensely in the urinary epithelium at the ureteropelvic junction in kidney. We found that targeted disruption of the mouse ADAMTS-1 gene resulted in enlarged renal calices accompanied by bilateral hydronephrosis and papillary atrophy approximately 4 weeks after birth. Electron microscopic examination revealed the fibrotic changes and hypervascularity of capillaries between the urinary epithelial cell layer and smooth muscle cell layer at the ureteropelvic junction.
CONCLUSION: ADAMTS-1 appears necessary for normal kidney morphology and function. Moreover, the resemblance of the renal phenotype to human ureteropelvic junction obstruction may provide a clue to the pathogenesis of this common congenital disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386284     DOI: 10.1093/ndt/17.suppl_9.39

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  Over-expression of Adamts1 in mice alters bone mineral density.

Authors:  Lijuan Hu; Kenneth B Jonsson; Harriet Andersén; Anne Edenro; Mohammad Bohlooly-Y; Håkan Melhus; Thomas Lind
Journal:  J Bone Miner Metab       Date:  2011-10-15       Impact factor: 2.626

2.  Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis.

Authors:  Yineng Fu; Janice A Nagy; Lawrence F Brown; Shou-Ching Shih; Pamela Y Johnson; Christina K Chan; Harold F Dvorak; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2011-03-16       Impact factor: 2.479

Review 3.  Current perspectives on congenital obstructive nephropathy.

Authors:  Susan E Ingraham; Kirk M McHugh
Journal:  Pediatr Nephrol       Date:  2011-02-17       Impact factor: 3.714

4.  Biosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanase.

Authors:  Carolyn M Dancevic; Fiona W Fraser; Adam D Smith; Nicole Stupka; Alister C Ward; Daniel R McCulloch
Journal:  J Biol Chem       Date:  2013-11-12       Impact factor: 5.157

Review 5.  The ADAMTS metalloproteinases.

Authors:  Sarah Porter; Ian M Clark; Lara Kevorkian; Dylan R Edwards
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

Review 6.  ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis.

Authors:  Gavin C Jones; Graham P Riley
Journal:  Arthritis Res Ther       Date:  2005-06-21       Impact factor: 5.156

7.  Selective decline of synaptic protein levels in the frontal cortex of female mice deficient in the extracellular metalloproteinase ADAMTS1.

Authors:  Matthew D Howell; Antoni X Torres-Collado; M Luisa Iruela-Arispe; Paul E Gottschall
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

8.  Comparative proteomic network signatures in seminal plasma of infertile men as a function of reactive oxygen species.

Authors:  Ashok Agarwal; Ahmet Ayaz; Luna Samanta; Rakesh Sharma; Mourad Assidi; Adel M Abuzenadah; Edmund Sabanegh
Journal:  Clin Proteomics       Date:  2015-08-28       Impact factor: 3.988

9.  Emerging Roles of ADAMTSs in Angiogenesis and Cancer.

Authors:  Saran Kumar; Nithya Rao; Ruowen Ge
Journal:  Cancers (Basel)       Date:  2012-11-29       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.